浙商银行 股份有限公司发布公告称,计划创设2026年度第一期“26 博瑞医药 MTN001( 科创债 )”信用风险缓释凭证,本期名义本金为3000万元。
Source Link浙商银行 股份有限公司发布公告称,计划创设2026年度第一期“26 博瑞医药 MTN001( 科创债 )”信用风险缓释凭证,本期名义本金为3000万元。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.